United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Sept. 11, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration ( FDA ) has accepted for review the New Drug Application (NDA) for Trevyent® (treprostinil) for the